# FDA 483 - Effingham Equity - June 06, 2023

Source: https://www.keypedia.com/records/483/effingham-equity/219ec496-44c0-4d29-95d0-196714c1deb4

> FDA 483 for Effingham Equity on June 06, 2023. Product: veterinary. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Effingham Equity
- Inspection Date: 2023-06-06
- Product Type: veterinary
- Office Name: Chicago District Office
- Summary: Effingham Equity, a medicated feed manufacturer in Effingham, IL, was cited for two significant issues during an FDA inspection. The firm failed to implement adequate preventive controls for aflatoxins in corn, specifically regarding sampling and analysis procedures. Additionally, the company did not perform required periodic assays for medicated feeds manufactured in 2022.

## Related Officers

- [Mark G. Peterson](https://www.keypedia.com/people/mark-g-peterson/a3442299-2fb5-4756-9155-4740d9ce0fa8)

Company: https://www.keypedia.com/companies/effingham-equity/d94eff98-850e-4059-9e34-c0f6f32e1153

Office: https://www.keypedia.com/offices/chicago-district-office/a510300b-0eaf-4a33-90b5-231d95977669